AVDL

Avadel Pharmaceuticals
AVDL

Overview Fund Activity

99 hedge funds and large institutions have $559M invested in Avadel Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 35 increasing their positions, 26 reducing their positions, and 16 closing their positions.

Holders
99
Holders Change
-2
Holders Change %
-1.98%
% of All Funds
1.58%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.1%
New
14
Increased
35
Reduced
26
Closed
16
Calls
$11M
Puts
$3.37M
Net Calls
+$7.59M
Net Calls Change
+$9.11M

Top Buyers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$110M
2
TCM
2
Tang Capital Management
California
$10.3M
3
RI
3
RTW Investments
New York
$73.5M
4
MB
4
MPM BioImpact
Massachusetts
$6.84M
5
KCM
5
Kennedy Capital Management
Missouri
$7.37M

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$0
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$17.8M
3
JPMPWA
3
J.P. Morgan Private Wealth Advisors
California
$0
4
PCM
4
Portolan Capital Management
Massachusetts
$0
5
CAC
5
Cowen and Company
New York
$24.1M
Name Market Value Shares Shares
Change 		Shares
Change %
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$110M 10,638,307 +3,115,762 +41%
RI
2
RTW Investments
New York
$73.5M 7,136,415 +325,774 +5%
GJL
3
Gendell Jeffrey L
$57.8M 5,615,350 +219,290 +4%
PCH
4
Polar Capital Holdings
United Kingdom
$46.5M 4,512,964 -21,957 -0.5%
VC
5
Vivo Capital
California
$42.2M 4,096,428 +266,851 +7%
WE
6
Wealth Effects
Massachusetts
$24.8M 2,409,289 +40,200 +2%
CAC
7
Cowen and Company
New York
$24.1M 2,338,302 -325,774 -12%
WP
8
Woodline Partners
California
$19.6M 1,902,843 +23,500 +1%
Adage Capital Partners
9
Adage Capital Partners
Massachusetts
$17.8M 1,725,000 -955,000 -36%
BIP
10
Brandes Investment Partners
California
$14.9M 1,448,772 +159,577 +12%
TCM
11
Tang Capital Management
California
$10.3M 1,000,000 +1,000,000 New
TLP
12
Tri Locum Partners
New York
$10.1M 983,602 -55,872 -5%
SB
13
Samsara BioCapital
California
$9.97M 967,527 – –
Renaissance Technologies
14
Renaissance Technologies
New York
$7.61M 738,906 +46,800 +7%
KCM
15
Kennedy Capital Management
Missouri
$7.37M 715,424 +268,704 +60%
MB
16
MPM BioImpact
Massachusetts
$6.84M 664,224 +279,234 +73%
KCM
17
Knoll Capital Management
Florida
$6.18M 600,000 +100,000 +20%
MWM
18
Modera Wealth Management
New Jersey
$6.12M 594,000 – –
D.E. Shaw & Co
19
D.E. Shaw & Co
New York
$5.66M 549,370 -216,466 -28%
Citadel Advisors
20
Citadel Advisors
Florida
$4.77M 463,105 -23,090 -5%
Marshall Wace
21
Marshall Wace
United Kingdom
$4.75M 460,803 -148,223 -24%
JPMorgan Chase & Co
22
JPMorgan Chase & Co
New York
$4.66M 452,472 +119,848 +36%
Deutsche Bank
23
Deutsche Bank
Germany
$4.53M 440,000 +215,000 +96%
Morgan Stanley
24
Morgan Stanley
New York
$4.5M 437,056 -24,038 -5%
Goldman Sachs
25
Goldman Sachs
New York
$3.72M 361,452 +148,653 +70%
1
2 3 4 5